Samalin Investment Counsel’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $594K | Buy |
|
|||||
|
2025
Q2 | $482K | Buy |
|
|||||
|
2025
Q1 | $459K | Sell |
|
|||||
|
2024
Q4 | $607K | Sell |
|
|||||
|
2024
Q3 | $896K | Sell |
|
|||||
|
2024
Q2 | $1.14M | Buy |
|
|||||
|
2024
Q1 | $1.03M | Buy |
|
|||||
|
2023
Q4 | $814K | Sell |
|
|||||
|
2023
Q3 | $738K | Sell |
|
|||||
|
2023
Q2 | $663K | Sell |
|
|||||
|
2023
Q1 | $652K | Buy |
|
|||||
|
2022
Q4 | $552K | Sell |
|
|||||
|
2022
Q3 | $426K | Sell |
|
|||||
|
2022
Q2 | $486K | Buy |
|
|||||
|
2022
Q1 | $478K | Hold |
|
|||||
|
2021
Q4 | $482K | Sell |
|
|||||
|
2021
Q3 | $415K | Buy |
|
|||||
|
2021
Q2 | $349K | Sell |
|
|||||
|
2021
Q1 | $284K | Sell |
|
|||||
|
2020
Q4 | $296K | Sell |
|
|||||
|
2020
Q3 | $301K | Buy |
|
|||||
|
2020
Q2 | $275K | Sell |
|
|||||
|
2020
Q1 | $506K | Sell |
|
|||||
|
2019
Q4 | $489K | Buy |
|